Doello, K.; Chico, M.A.; Quiñonero, F.; Ortiz, R.; Prados, J.; Mesas, C.; Melguizo, C.
Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide. Medicina 2024, 60, 1039.
https://doi.org/10.3390/medicina60071039
AMA Style
Doello K, Chico MA, Quiñonero F, Ortiz R, Prados J, Mesas C, Melguizo C.
Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide. Medicina. 2024; 60(7):1039.
https://doi.org/10.3390/medicina60071039
Chicago/Turabian Style
Doello, Kevin, Maria Angeles Chico, Francisco Quiñonero, Raúl Ortiz, Jose Prados, Cristina Mesas, and Consolación Melguizo.
2024. "Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide" Medicina 60, no. 7: 1039.
https://doi.org/10.3390/medicina60071039
APA Style
Doello, K., Chico, M. A., Quiñonero, F., Ortiz, R., Prados, J., Mesas, C., & Melguizo, C.
(2024). Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide. Medicina, 60(7), 1039.
https://doi.org/10.3390/medicina60071039